title: [Are some antidiabetic drugs also drugs useful for heart failure treatment?].
abstract: The prevalence of diabetes mellitus type 2 is rapidly growing. It is the cardiovascular mortality and morbidity why these patients suffer. Also heart failure becomes very frequent in diabetics, as it is a strong risk factor for development of heart failure and for its progression. Recently published data of EMPA-REG OUTCOME trial with empagliflozin hint to the possibility of heart failure treatment with this drug. The author presents data about the influence of antidiabetic drugs on cardiovascular risk factors, specifically on heart failure. This can be a way how to prevent heart failure in diabetic patients. Later he presents data about the influence of antidiabetics on symptoms and signs of heart failure. Some of these drugs are neutral, some are risky for patients and in the case of empagliflozin there is a beneficial influence. As heart failure is a great problem of clinical practice and diabetes is a strong risk factor of heart failure, we are looking also for prevention of heart failure and for its treatment also by using antidiabetic drug.
authors.forename: Ján
authors.initials: J
authors.lastname: Murín
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005960:Glucosides / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D001559:Benzhydryl Compounds; D002316:Cardiotonic Agents; D005960:Glucosides; D007004:Hypoglycemic Agents; C570240:empagliflozin